Transitioning to Fully-Fledge Business Model
Egyptian International Pharmaceuticals-EIPICO (PHAR.CA) is pursuing being a fully-fledged business model with the localization of raw material production, currently it operates through semi-fledged business model that comprises full-spectrum line of pharmaceutical products with vertically integrated supply chain through subsequent packaging process. EIPICO produces over 400 diversified pharmaceutical non-cosmetics products, including sterile and non-sterile products, as well as KSA-based Batterjee Pharma factory thirty products, in addition various packing forms.
Disclaimer
The contents of this report were prepared by Tycoon Research of Tycoon Securities Brokerage Company, for the purpose of knowledge and information, and this report cannot in any way be considered an incentive to make an investment decision. Information, estimates and analyzes contained in research reports or documents are as of the date published and are subject to change without notice. The information and opinions contained in the reports and documents have been compiled from reliable sources, but no representation or warranty is made, express or implied, as to their accuracy or reliability. Research reports and all opinions, conclusions and analyzes of the information contained therein are protected by copyright. Research reports or documents may not be republished or distributed, in whole or in part, without obtaining explicit approval from Tycoon Securities Brokerage. All research reports and documents are based on information of a general nature and represent the analyst's point of view, and Tycoon Research is not responsible for any decisions taken based on what is contained in the reports or research.
